SELECTION:
- An enduring threat: NPS benzodiazepines in forensic and clinical toxicology from 2021 to 2025. Ellefsen K.N., Karschner E.L., Mérette S.A.M., Patton A.L., Shoff E.N., Smith C.R., et al., art. bkag026.
- N-pyrrolidino isotonitazene and its metabolites in post-mortem casework. Wood R., Moore R., art. bkag027.
- Comment on Deeb et al.: interpretation of breath cannabinoids and implications for impairment. Olson A., art. bkag028.
- A retrospective review of phencyclidine in hair samples of subjects from the United States workplace drug testing population. Stowe G.N., Loni E., Gonzalez A., Furukawa R., Paulsen R.B., Schaffer M.I., et al., art. bkag029.
- Studies on enzymatic hydrolysis of psilocin-O-glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry. Barajas D.A., Carter H.C.N., Tomedi M.R., Lam H.Y., Deloatch T.N., Reynolds G.D., et al., art. bkag030.
- Determination of nitazenes in postmortem casework and their prevalence in the State of Maryland. Fagiola M., Phipps R., art. bkag031.
- Postmortem redistribution and quantitative analysis of bromazolam, etizolam, flualprazolam, and flubromazolam. Shoff E.N., Kahl J.H., Moore D.M., art. bkag033.
- In vitro metabolic profile characterization for synthetic cannabinoids MDMB-BINACA, MDMB-PICA, and AB-CHMINACA. Eccarius L.K., Stang B.N., Walton S.E., Krotulski A.J., Logan B.K., art. bkag034.
- Prevalence of p-fluorofentanyl and xylazine in postmortem fentanyl casework. Ballotari M., Truver M.T., Hoyer J.L., Goldberger B.A., Chronister C.W., art. bkag035.
- Comprehensive toxicological characterization and quantitation of drugs identified among nonfatal opioid and stimulant overdose presentations to US emergency departments. Stang B.N., Kent J.T., Walton S.E., Aldy K., Culbreth R., Falise A., et al., art. bkag036.
- Variability in breath alcohol concentration profiles during controlled social drinking. O'Connor R.S., Wang J., Vargas J.R., art. bkag038.
- In response to letter to editor JAT-26-4812-Interpretation of breath cannabinoids and implications for impairment. Deeb S., Fabian Z.E., Määttä M., Fraccarolli P., Engelhart D.A., art. bkag039.
- Evaluation of gabapentin: a 7-year review of postmortem and driving while intoxicated cases in Dallas County. Dempsey S.K., Glicksberg L.C., art. bkag040.
- Mitragynine and 7-hydroxy-mitragyine plasma pharmacokinetics in humans after single and 15 multiple oral kratom extract doses. Huestis M.A., Brett M.A., Bothmer J., Henningfield J.E., Swift S., art. bkag042.
- Characterization of postmortem ?-hydroxybutyric acid (GHB) and a novel model to discern exogenous use. Pearring S., Tchu S., Desharnais B., Doyon A., Mireault P., Elliott S., et al., art. bkag046.
- Differential addictive potential of cis- and trans-3-methylfentanyl revealed by pharmacokinetic-pharmacodynamic profiling. Bai X., Chen Y., Wei Z.Q., Bian J., Zhou C.M., Lv L.H., et al., art. bkag049.
- Development and application of a simplified, quantitative method for 30+ New Psychoactive Substances in hair. Hwang S., Dos Santos B.P., Ameer A., Schwarz P.S., Birk L., Salomone A., et al., art. bkag052.
- Evaluation of a rapid immunoenzymatic screening kit (SAMElife™) for drugs of abuse detection in hair. Martini V., Ortu S., Stramesi C., Vignali C., Morini L., art. bkag053.
- Development and validation of a quantitative analytical method for urine samples in drug-facilitated sexual assault cases. Denkena I.L., Martins A.F., Rodrigues L.C., Lanaro R., de Azevedo R.C.S., Santos M.G.G., et al., art. bkag054.
- Drug detection in traffic-related fatalities in Connecticut (2020-2024). Mohr A.L.A., Gill J.R., Logan B.K., art. bkag055.
- Differentiation of 2-, 3-, and 4-fluorofuranylfentanyl using high performance liquid chromatography-mass spectrometry and human liver microsomes. Iwaki T., Oida Y., Morikawa M., Itoh K., Iwai K., Abe K., et al., art. bkag056.
- Trends and circumstances of pediatric fentanyl deaths in North Carolina: a 10-year retrospective study. Welch M., Friederich L.W., Cox M.E., Aurelius M.B., Bishop-Freeman S.C., art. bkag057.
- Is drug facilitated sexual assault changing? About a case involving 4-bromomethcathinone. Schiestel T., Magny R., Minka H.F., Langrand J., Houzé P., Labat L., art. bkag058.